Company page

Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing cellular immunotherapies for cancer and immune disorders. The company is traded under the ticker symbol FATE and has a market capitalization of approximately $280.9 million. Fate Therapeutics aims to advance its innovative therapies through research and development in the field of regenerative medicine.